Opportunistic breast cancer early detection in Tyrol, Austria 1996-2004. Is a mammography-screening program necessary? von Frede, Thomas E

Volltext

Opportunistic breast cancer early detection in Tyrol, Austria 1996–2004 von Frede, Thomas E.

Volltext

Opportunistic breast cancer early detection in Tyrol, Austria 1996-2004 Is a mammography-screening program necessary?: Bone Marrow Imaging in MRI von FREDE, Thomas E

Volltext

Anatomy of the eustachian tube as demonstrated by endoluminal ultrasonography von Helweg, G, Frauscher, F, Sprinzl, G. M, Gotwald, T, Volklein, C, Knapp, R. J, Sogner, P. F, Maurer, H, Frede, T. E, zur Nedden, D

Volltext

Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma von Choueiri, Toni K, Escudier, Bernard, Powles, Thomas, Mainwaring, Paul N, Rini, Brian I, Donskov, Frede, Hammers, Hans, Hutson, Thomas E, Lee, Jae-Lyun, Peltola, Katriina, Roth, Bruce J, Bjarnason, Georg A, Géczi, Lajos, Keam, Bhumsuk, Maroto, Pablo, Heng, Daniel Y.C, Schmidinger, Manuela, Kantoff, Philip W, Borgman-Hagey, Anne, Hessel, Colin, Scheffold, Christian, Schwab, Gisela M, Tannir, Nizar M, Motzer, Robert J

Volltext

Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial von Choueiri, Toni K, Dr, Escudier, Bernard, MD, Powles, Thomas, Prof, Tannir, Nizar M, Prof, Mainwaring, Paul N, MD, Rini, Brian I, Prof, Hammers, Hans J, MD, Donskov, Frede, MD, Roth, Bruce J, Prof, Peltola, Katriina, MD, Lee, Jae Lyun, Prof, Heng, Daniel Y C, MD, Schmidinger, Manuela, Prof, Agarwal, Neeraj, MD, Sternberg, Cora N, Prof, McDermott, David F, MD, Aftab, Dana T, PhD, Hessel, Colin, MS, Scheffold, Christian, MD, Schwab, Gisela, MD, Hutson, Thomas E, Prof, Pal, Sumanta, MD, Motzer, Robert J, Prof

Volltext

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma von Motzer, Robert J, Escudier, Bernard, McDermott, David F, George, Saby, Hammers, Hans J, Srinivas, Sandhya, Tykodi, Scott S, Sosman, Jeffrey A, Procopio, Giuseppe, Plimack, Elizabeth R, Castellano, Daniel, Choueiri, Toni K, Gurney, Howard, Donskov, Frede, Bono, Petri, Wagstaff, John, Gauler, Thomas C, Ueda, Takeshi, Tomita, Yoshihiko, Schutz, Fabio A, Kollmannsberger, Christian, Larkin, James, Ravaud, Alain, Simon, Jason S, Xu, Li-An, Waxman, Ian M, Sharma, Padmanee

Volltext

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma von Motzer, Robert J, Tannir, Nizar M, McDermott, David F, Arén Frontera, Osvaldo, Melichar, Bohuslav, Choueiri, Toni K, Plimack, Elizabeth R, Barthélémy, Philippe, Porta, Camillo, George, Saby, Powles, Thomas, Donskov, Frede, Neiman, Victoria, Kollmannsberger, Christian K, Salman, Pamela, Gurney, Howard, Hawkins, Robert, Ravaud, Alain, Grimm, Marc-Oliver, Bracarda, Sergio, Barrios, Carlos H, Tomita, Yoshihiko, Castellano, Daniel, Rini, Brian I, Chen, Allen C, Mekan, Sabeen, McHenry, M. Brent, Wind-Rotolo, Megan, Doan, Justin, Sharma, Padmanee, Hammers, Hans J, Escudier, Bernard

Volltext

Quality of Life Outcomes for Cabozantinib Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma: METEOR Phase III Randomized Trial von Cella, David, Escudier, Bernard, Tannir, Nizar M, Powles, Thomas, Donskov, Frede, Peltola, Katriina, Schmidinger, Manuela, Heng, Daniel Y C, Mainwaring, Paul N, Hammers, Hans J, Lee, Jae Lyun, Roth, Bruce J, Marteau, Florence, Williams, Paul, Baer, John, Mangeshkar, Milan, Scheffold, Christian, Hutson, Thomas E, Pal, Sumanta, Motzer, Robert J, Choueiri, Toni K

Volltext

Technical solutions to improve the management of non‐muscle‐invasive transitional cell carcinoma: summary of a European Association of Urology Section for Uro‐Technology (ESUT) and... von Bach, Thorsten, Muschter, Rolf, Herrmann, Thomas R.W., Knoll, Thomas, Scoffone, Cesare M., Laguna, M. Pilar, Skolarikos, Andreas, Rischmann, Pascal, Janetschek, Günter, De la Rosette, Jean J.M.C.H., Nagele, Udo, Malavaud, Bernard, Breda, Alberto, Palou, Juan, Bachmann, Alexander, Frede, Thomas, Geavlete, Petrisor, Liatsikos, Evangelos, Jichlinski, Patrice, Schwaibold, Hartwig E., Chlosta, Piotr, Martov, Alexey G., Lapini, Alberto, Schmidbauer, Joerg, Djavan, Bob, Stenzl, Arnulf, Brausi, Mauricio, Rassweiler, Jens J.

Volltext

Hip fracture evaluation with alternatives of total hip arthroplasty versus hemiarthroplasty (HEALTH): protocol for a multicentre randomised trial von Bhandari, Mohit, Devereaux, P J, Einhorn, Thomas A, Thabane, Lehana, Schemitsch, Emil H, Koval, Kenneth J, Frihagen, Frede, Poolman, Rudolf W, Tetsworth, Kevin, Guerra-Farfán, Ernesto, Madden, Kim, Sprague, Sheila, Guyatt, Gordon

Volltext

Automated detection and quantification of reverse triggering effort under mechanical ventilation von Pham, Tài, Montanya, Jaume, Telias, Irene, Piraino, Thomas, Magrans, Rudys, Coudroy, Rémi, Damiani, L Felipe, Mellado Artigas, Ricard, Madorno, Matías, Blanch, Lluis, Brochard, Laurent

Volltext

IMmotion151: A Randomized Phase III Study of Atezolizumab Plus Bevacizumab vs Sunitinib in Untreated Metastatic Renal Cell Carcinoma (mRCC) von Motzer, Robert J., Powles, Thomas, Atkins, Michael B., Escudier, Bernard, McDermott, David F., Suarez, Cristina, Bracarda, Sergio, Stadler, Walter Michael, Donskov, Frede, Lee, Jae-Lyun, Hawkins, Robert E., Ravaud, Alain, Alekseev, Boris Y., Staehler, Michael D., Uemura, Motohide, Donaldson, Francis, Li, Shi, Huseni, Mahrukh A., Schiff, Christina, Rini, Brian I.

Volltext

Treatment-free survival (TFS) after discontinuation of first-line nivolumab (NIVO) plus ipilimumab (IPI) or sunitinib (SUN) in intention-to-treat (ITT) and IMDC favorable-risk pati... von McDermott, David F., Rini, Brian I., Motzer, Robert J., Tannir, Nizar M., Escudier, Bernard, Kollmannsberger, Christian K., Hammers, Hans J., Porta, Camillo, George, Saby, Donskov, Frede, Gurney, Howard, Grimm, Marc-Oliver, Harrison, Michael Roger, Hutson, Thomas E., Yang, Shuo, Johansen, Jennifer, Rao, Sumati, Mekan, Sabeen Fatima, Rael, Michael, Powles, Thomas

Volltext

CABOSEQ: The Effectiveness of Cabozantinib in Patients With Treatment Refractory Advanced Renal Cell Carcinoma: Results From the International Metastatic Renal Cell Carcinoma Datab... von Navani, Vishal, Wells, J Connor, Boyne, Devon J, Cheung, Winson Y, Brenner, Darren M, McGregor, Bradley A, Labaki, Chris, Schmidt, Andrew L, McKay, Rana R, Meza, Luis, Pal, Sumanta K, Donskov, Frede, Beuselinck, Benoit, Otiato, Maxwell, Ludwig, Lisa, Powles, Thomas, Szabados, Bernadett E, Choueiri, Toni K, Heng, Daniel Y C

Volltext

CABOSEQ: The Effectiveness of Cabozantinib in Patients With Treatment Refractory Advanced Renal Cell Carcinoma: Results From the International Metastatic Renal Cell Carcinoma Datab... von Navani, Vishal, Wells, J. Connor, Boyne, Devon J, Cheung, Winson Y, Brenner, Darren M, McGregor, Bradley A, Labaki, Chris, Schmidt, Andrew L, McKay, Rana R, Meza, Luis, Pal, Sumanta K, Donskov, Frede, Beuselinck, Benoit, Otiato, Maxwell, Ludwig, Lisa, Powles, Thomas, Szabados, Bernadett E, Choueiri, Toni K, Heng, Daniel Y.C

Volltext

Atezolizumab (atezo) + bevacizumab (bev) versus sunitinib (sun) in pts with untreated metastatic renal cell carcinoma (mRCC) and sarcomatoid (sarc) histology: IMmotion151 subgroup... von Rini, Brian I., Motzer, Robert J., Powles, Thomas, McDermott, David F., Escudier, Bernard, Donskov, Frede, Hawkins, Robert E., Bracarda, Sergio, Bedke, Jens, De Giorgi, Ugo, Porta, Camillo, Ravaud, Alain, Parnis, Francis, Grande, Enrique, Zhang, Wei, Huseni, Mahrukh A., Carroll, Susheela, Sufan, Roxana Ioana, Schiff, Christina, Atkins, Michael B.

Volltext

Reliability of the classification of proximal femur fractures: Does clinical experience matter? von Crijns, Tom J., Janssen, Stein J., Davis, Jacob T., Ring, David, Sanchez, Hugo B., Althausen, Peter, Amini, Michael H., Appleton, Paul, Babis, George C., Babst, Reto H., Ballas, Efstathios G., Barquet, Antonio, Begue, Thierry, Bishop, Julius, Borris, Lars C., Buckley, Richard, Chesser, Tim, Choudhari, Pradeep, Cornell, Charles, Crist, Brett D., DeCoster, Thomas A., Elias, Nelson, Frihagen, Frede, Garnavos, Christos, Giordano, Vincenzo, Haverlag, R., Havlicek, Tomo, Hurwit, Shep, Ibrahim, Edward F., Iyer, Vishwanath M., Jenkinson, Richard, Jeray, Kyle, Kabir, Koroush, Kanakaris, Nikolaos K., Klostermann, Cyrus, Kreder, Hans J., Kreis, B.E., Kristan, Anze, Lygdas, P., McGraw, Iain, Mica, Ladislav, Mirck, B., Moreta-Suarez, Jesus, Morgan, Steven J., Nikolaou, Vassilios S., Omara, Timothy, Pesantez, Rodrigo, Pirpiris, Marinis, Poelhekke, L.M.S.J., Pountos, Ippokratis, Prayson, Michael, Quell, M., Rodríguez-Roiz, Juan M., Satora, Wojciech, Schandelmaier, Peter, Schepers, T., Short, Nicholas L., Smith, Raymond M., Spoor, A.B., Stojkovska Pemovska, Emilija, Swiontkowski, Marc, Taitsman, Lisa, Tosounidis, Theodoros, Tyllianakis, Minos, Van bergen, C.J.A., Van de Sande, M.A.J., Van Helden, S.H., Verbeek, Diederik O., Wascher, Daniel C., Weil, Yoram

Volltext

Defining the Differentiation States of Multiple Myeloma at Single Cell Resolution Reveals Opportunities for Immunotherapy von Frede, Julia, Anand, Praveen, Yee, Andrew J., Vijaykumar, Tushara, Nair, Monica S., Waldschmidt, Johannes M., Potdar, Sayalee V., Kloeber, Jake A., Kokkalis, Antonis, Guo, Guangwu, Shapiro, Samantha J., Mann, Mason L., Friedman, Robb S, Lipe, Brea C., Campagnaro, Erica L., Cole, Craig E., O'Donnell, Elizabeth K., Guerrero, Thomas, Nadeem, Omar, Laubach, Jacob P., Munshi, Nikhil C., Richardson, Paul G., Anderson, Kenneth C., Raje, Noopur, Knoechel, Birgit, Lohr, Jens G.

Volltext

Overall survival (OS) in METEOR, a randomized phase 3 trial of cabozantinib (Cabo) versus everolimus (Eve) in patients (pts) with advanced renal cell carcinoma (RCC) von Choueiri, Toni K., Powles, Thomas, Escudier, Bernard J., Tannir, Nizar M., Mainwaring, Paul, Rini, Brian I., Hammers, Hans J., Donskov, Frede, Roth, Bruce J., Peltola, Katriina, Lee, Jae-Lyun, Heng, Daniel Yick Chin, Schmidinger, Manuela, Aftab, Dana T., Hessel, Colin, Scheffold, Christian, Schwab, Gisela, Pal, Sumanta K., Hutson, Thomas E., Motzer, Robert J.

Volltext